OUR COMMITMENT
FOR PATIENTS, CAREGIVERS, LOVED ONES, ADVOCATES & HEALTHCARE SPECIALISTS
The people living with, supporting and treating those with neurological conditions are at the center of what we do. We are grateful for the opportunity to have relationships, partnerships and education that has come from working closely with the community globally, from patients and families, to advocacy leaders and healthcare providers. Your contributions and feedback are crucial to the success in finding safe and effective treatments for a wide range of neurological conditions. We hear you and are working diligently towards our goal of developing novel, transformative medicines.
Thank you for allowing us to be a part of the community.
About the PACIFIC Study
In January 2024, Longboard reported topline results from the PACIFIC Study, a Phase 1b/2a double-blind, placebo-controlled clinical trial to assess the safety, tolerability, efficacy and pharmacokinetics of bexicaserin (LP352) in 52 participants between the ages of 12 and 65 years old at 34 sites across the United States and Australia. Following a 5-week screening period and baseline evaluations, study participants initiated a dose titration over a 15-day period and subsequently continued on the highest tolerated dose throughout the maintenance period of 60 days. Following the maintenance period, participants were then titrated down, and eligible participants were given the opportunity to enroll in a 52-week open-label extension program. The primary efficacy measure was median percent change from baseline in countable motor seizure frequency over the 75-day treatment period. Learn more about PACIFIC here.
At Longboard, we are committed to providing personalized support services throughout a patient and caregiver’s journey. Through this commitment, we have developed Longboard Assist, our internally developed program which includes patient service and support across several key areas including disease and education treatment and assistance in clinical study participation including telehealth and home health services, transportation, lodging, etc.
Reach Out
For questions or comments please feel free to reach out to us directly at [email protected].
For questions or comments please feel free to reach out to us directly through email.
Advocacy & Research Partnerships
We have engaged multiple advocacy and research groups across the DEE landscape in order to optimize the design of the PACIFIC study, increase study awareness in the community, and to enrich our understanding of the evolving DEE environment.
